Patil Neena M's Form 4 filing
Jazz Pharmaceuticals plc (JAZZ) · filed Mar 2, 2026
- Accession no.
- 0001783908-26-000007
- Filed
- Mar 2, 2026
- Trade date
- Feb 26, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 16 non-derivative transactions and 4 derivative transactions. Open-market sales total $10.7M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patil Neena MCIK 0001783908 | Officer (EVP & Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Ordinary Shares | MOption exerciseAcquired | +20,125 | $113.10 | +$2,276,137.5 | 73,464 | Direct | |
| Feb 26, 2026 | Ordinary Shares | SSaleDisposed | −16,602 | $192.53 | −$3,196,383.06 | 56,862 | Direct | |
| Feb 26, 2026 | Ordinary Shares | MOption exerciseAcquired | +875 | $113.10 | +$98,962.5 | 57,737 | Direct | |
| Feb 26, 2026 | Ordinary Shares | SSaleDisposed | −875 | $192.07 | −$168,061.25 | 56,862 | Direct | |
| Feb 26, 2026 | Ordinary Shares | MOption exerciseAcquired | +27,084 | $137.12 | +$3,713,758.08 | 83,946 | Direct | |
| Feb 26, 2026 | Ordinary Shares | SSaleDisposed | −15,555 | $190.28 | −$2,959,805.4 | 68,391 | Direct | |
| Feb 26, 2026 | Ordinary Shares | MOption exerciseAcquired | +2,916 | $137.12 | +$399,841.92 | 71,307 | Direct | |
| Feb 26, 2026 | Ordinary Shares | SSaleDisposed | −2,916 | $189.81 | −$553,485.96 | 68,391 | Direct | |
| Feb 26, 2026 | Ordinary Shares | AGrant or awardAcquired | +10,079 | $0.00 | $0 | 78,470 | Direct | |
| Feb 26, 2026 | Ordinary Shares | SSaleDisposed | −11,529 | $191.65 | −$2,209,532.85 | 66,941 | Direct | |
| Feb 26, 2026 | Ordinary Shares | SSaleDisposed | −3,523 | $193.58 | −$681,982.34 | 63,418 | Direct | |
| Feb 26, 2026 | Ordinary Shares | SSaleDisposed | −1,061 | $190.00 | −$201,590 | 62,357 | Direct | |
| Feb 26, 2026 | Ordinary Shares | SSaleDisposed | −549 | $190.80 | −$104,749.2 | 61,808 | Direct | |
| Feb 26, 2026 | Ordinary Shares | SSaleDisposed | −1,784 | $191.88 | −$342,313.92 | 60,024 | Direct | |
| Feb 26, 2026 | Ordinary Shares | SSaleDisposed | −1,009 | $192.79 | −$194,525.11 | 59,015 | Direct | |
| Feb 26, 2026 | Ordinary Shares | SSaleDisposed | −197 | $193.60 | −$38,139.2 | 58,818 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Ordinary Shares | MOption exerciseDisposed | −875 | $0.00 | $0 | 0 | Direct | |
| Feb 26, 2026 | Ordinary Shares | MOption exerciseDisposed | −2,916 | $0.00 | $0 | 0 | Direct | |
| Feb 26, 2026 | Ordinary Shares | MOption exerciseDisposed | −20,125 | $0.00 | $0 | 0 | Direct | |
| Feb 26, 2026 | Ordinary Shares | MOption exerciseDisposed | −27,084 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.